- Performance of the Dual AntiPlatelet Therapy (DAPT) Score in the ADAPT-DES StudyBrener, Sorin; Kirtane, Ajay Jayant; Rinaldi, Michael; Witzenbichler, Bernhard; Neumann, Franz-Josef; Henry, Timothy; Cox, David; Duffy, Peter L.; Mazzaferri, Ernest, Jr.; Brodie, Bruce; Mehran, Roxana; McAndrew, Thomas; Stone, Gregg29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Denver, CO, 2017-10-29 To 2017-11-02.
- Long-term outcomes of triple antithrombotic therapy (TT) versus dual antiplatelet therapy (NoTT) after coronary stenting: up to 4-years of follow-upDe La Rosa A; Del Castillo R; Hernando L; Canovas E; Salinas P; Freites A J; Alonso J; Montalvo G; Huelmos A M; Botas JCongress of the European-Society-of-Cardiology (ESC), 2013-08-31 To 2013-09-04.
- Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After PCI: Analysis from the ADAPT-DES studyRedfors, Bjorn; Huang, Xin; Witzenbichler, Bernhard; Chen, Shmuel; Liu, Yangbo; Brodie, Bruce; Rinaldi, Michael; Henry, Timothy; Cox, David; Duffy, Peter L.; Mazzaferri, Ernest, Jr.; Mehran, Roxana; Kirtane, Ajay Jayant; Ben-Yehuda, Ori; Stone, Gregg29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Denver, CO, 2017-10-29 To 2017-11-02.
会议论文
Risk assessment of premature discontinuation of dual antiplatelet therapy in patients undergoing vascular surgery after second generation DES implantation
18阅读
